IMS Capital Management Makes New Investment in HCA Healthcare, Inc. (NYSE:HCA)

IMS Capital Management purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 1st quarter, HoldingsChannel reports. The firm purchased 620 shares of the company’s stock, valued at approximately $207,000.

Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of HCA Healthcare by 0.4% in the 1st quarter. Vanguard Group Inc. now owns 16,989,683 shares of the company’s stock valued at $5,666,569,000 after acquiring an additional 60,304 shares during the last quarter. Sanders Capital LLC increased its holdings in shares of HCA Healthcare by 4.2% in the 4th quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock valued at $3,086,836,000 after acquiring an additional 456,738 shares during the last quarter. Wellington Management Group LLP increased its holdings in shares of HCA Healthcare by 1.7% in the 4th quarter. Wellington Management Group LLP now owns 10,186,129 shares of the company’s stock valued at $2,757,181,000 after acquiring an additional 170,560 shares during the last quarter. Royal Bank of Canada increased its holdings in shares of HCA Healthcare by 35.7% in the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after acquiring an additional 1,183,890 shares during the last quarter. Finally, Capital World Investors boosted its position in shares of HCA Healthcare by 57.5% in the 1st quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock valued at $931,342,000 after purchasing an additional 1,019,750 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on HCA shares. TD Cowen decreased their target price on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Truist Financial upped their target price on HCA Healthcare from $375.00 to $390.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft increased their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a “buy” rating in a research report on Friday, June 28th. Robert W. Baird began coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 price objective for the company. Finally, JPMorgan Chase & Co. increased their price objective on HCA Healthcare from $327.00 to $332.00 and gave the stock a “neutral” rating in a research report on Thursday, May 30th. Four analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $344.06.

Insider Transactions at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 6,311 shares of the firm’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total transaction of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares in the company, valued at $9,387,253.12. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, SVP Christopher F. Wyatt sold 4,000 shares of HCA Healthcare stock in a transaction on Monday, July 29th. The stock was sold at an average price of $360.20, for a total value of $1,440,800.00. Following the transaction, the senior vice president now owns 40,449 shares in the company, valued at $14,569,729.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of HCA Healthcare stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $316.88, for a total value of $1,999,829.68. Following the completion of the transaction, the executive vice president now owns 29,624 shares in the company, valued at approximately $9,387,253.12. The disclosure for this sale can be found here. Insiders have sold 20,268 shares of company stock worth $6,804,285 over the last quarter. 1.60% of the stock is currently owned by insiders.

HCA Healthcare Price Performance

NYSE HCA traded down $6.76 during mid-day trading on Friday, hitting $356.36. The stock had a trading volume of 1,604,536 shares, compared to its average volume of 1,536,892. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The company has a 50 day simple moving average of $334.20 and a 200 day simple moving average of $324.97. The company has a market cap of $91.97 billion, a price-to-earnings ratio of 17.76, a P/E/G ratio of 1.39 and a beta of 1.68. HCA Healthcare, Inc. has a 52-week low of $215.96 and a 52-week high of $369.41.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion during the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. HCA Healthcare’s revenue was up 10.3% compared to the same quarter last year. During the same quarter last year, the business posted $4.29 earnings per share. Equities analysts forecast that HCA Healthcare, Inc. will post 22.43 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, September 30th. Stockholders of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.74%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.